Nitin Pal Kalia

1.9k citations
67 papers · 1.3k indexed · h-index 18

Nitin Pal Kalia

63 papers receiving 1.2k citations

Peers

Nitin Pal Kalia
Comparison fields: 5 of 96
  • Molecular Medicine 253
  • Infectious Diseases 498
  • Pharmacology 157
  • Organic Chemistry 277
  • Molecular Biology 649
Replace Amit Nargotra with:
Amit Nargotra India
Dimitrios Evangelopoulos United Kingdom
Sandeep Sharma India
Cecília Rocha da Silva Brazil
João Batista de Andrade Neto Brazil
Tarek S. Ibrahim Egypt
Juan Guzman United Kingdom
Mona I. Shaaban Egypt
Shutao Ma China
Sandrine Alibert France
Nitin Pal Kalia relative to Amit Nargotra India Amit Nargotra's profile →
Citations per field
00.5×6.3×
Amit Nargotra · 1×
Citations per year

Countries citing papers authored by Nitin Pal Kalia

Since Specialization
Citations

This map shows the geographic impact of Nitin Pal Kalia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nitin Pal Kalia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nitin Pal Kalia more than expected).

Fields of papers citing papers by Nitin Pal Kalia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nitin Pal Kalia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nitin Pal Kalia. The network helps show where Nitin Pal Kalia may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nitin Pal Kalia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nitin Pal Kalia Line = papers co-authored together Nitin Pal Kalia links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20255
2 20252
3 20252
4 20250
5 20250
6 20246
7 20246
8 20247
9 20243
10 20238
11 20233
12 20236
13 202317
14 202321
15 20237
16 20212
17 202015
18 201927
19 201852
20 201261

About Nitin Pal Kalia

Nitin Pal Kalia is a scholar working on Infectious Diseases, Microbiology and Molecular Medicine, having authored 67 papers that have together received 1.3k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (29 papers), Cancer therapeutics and mechanisms (15 papers), Mycobacterium research and diagnosis (13 papers), Phenothiazines and Benzothiazines Synthesis and Activities (12 papers), Synthesis and biological activity (8 papers), Biochemical and Molecular Research (8 papers), Synthesis and Biological Evaluation (7 papers) and Antimicrobial Peptides and Activities (6 papers). The work is most often cited by research in Molecular Medicine (253 citations), Infectious Diseases (498 citations) and Pharmacology (157 citations). Nitin Pal Kalia has collaborated with scholars based in India, Singapore and United States. Frequent co-authors include Inshad Ali Khan, Kévin Pethe, Ashwani Kumar, Rukmankesh Mehra, Amit Nargotra, Vikrant Singh Rajput, J.P. Sharma, Supriya Koul, Priya Mahajan and Michael Berney. Their work appears in journals such as RSC Medicinal Chemistry, Archiv der Pharmazie, European Journal of Medicinal Chemistry, Drug Discovery Today and Journal of Medical Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026